AI is about to change healthcare. These 39 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own Wiley, you need to believe it can keep shifting from legacy print and subscription models toward higher value digital, data, and AI services. The new spectral analysis APIs fit that thesis by packaging Wiley’s scientific data as an infrastructure-like service, although the most immediate swing factor still looks to be volatility in AI content licensing revenue, while pressure from open access and alternative publishing models remains a central risk.
The spectral APIs sit alongside Wiley’s broader AI and data push, including the 2025 launch of Wiley AI Gateway, which connects publishers’ content with AI tools via an open interoperability standard. Together, these initiatives tie directly into the key catalyst of expanding data and analytics partnerships beyond traditional academia, but they also bring execution risk if research funding or adoption of vendor neutral platforms underwhelms expectations.
Yet this growing reliance on less predictable AI and data licensing is exactly the kind of risk investors should be aware of if Wiley’s newer revenue streams...
Read the full narrative on John Wiley & Sons (it's free!)
John Wiley & Sons' narrative projects $1.9 billion revenue and $224.2 million earnings by 2029. This requires 4.7% yearly revenue growth and a modest $2.6 million earnings increase from $221.6 million today.
Uncover how John Wiley & Sons' forecasts yield a $68.00 fair value, a 27% upside to its current price.
Two fair value estimates from the Simply Wall St Community span roughly US$68 to about US$92.74, showing how far apart individual views can be. Against this, Wiley’s push into AI and data driven products, including spectral and research APIs, raises important questions about how resilient earnings might be if newer revenue streams fluctuate, so it can be useful to compare several of these perspectives before forming your own view.
Explore 2 other fair value estimates on John Wiley & Sons - why the stock might be worth as much as 73% more than the current price!
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
Our daily scans reveal stocks with breakout potential. Don't miss this chance:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com